HTR7 and schizophrenia: Although modulating 5-HT7 is one of the targets for the treatment of schizophrenia and mood and anxiety disorders in current psychopharmacology, unfortunately, the clinical application of selective 5-HT7 receptor modulators has not yet been achieved [16].